373
Participants
Start Date
June 30, 2014
Primary Completion Date
July 31, 2015
Study Completion Date
July 31, 2015
nalbuphine HCl ER tablets 60 mg BID
nalbuphine HCl ER tablets 60 mg BID administered for 6 weeks
nalbuphine HCl ER tablets 120mg BID
nalbuphine HCl ER tablets 120mg BID administered for 6 weeks
Placebo tablets BID
Placebo tablets BID administered for 8 weeks
Newtown Dialysis Center, Inc, College Point
DaVita Northtown's Dialysis Center, Tonawanda
Nephrology Research Consortium, Bethlehem
Delaware Valley Nephrology, Philadelphia
Dialysis Clinic Inc., Philadelphia
Brookview Hills Research Associates LLC, Winston-Salem
Wake Nephrology Associates PA, Raleigh
Durham Nephrology Associates, Durham
South Carolina Nephrology and Hypertension, Orangeburg
Carolina Diabetes and Kidney Center, Sumter
South Carolina Nephrology and Hypertension, Hampton
Renal Physicians of Georgia, Macon
Southwest Georgia Nephrology Clinic PC, Albany
DaVita Central Orlando Dialysis, Winter Park
Pines Clinical Research Inc, Pembroke Pines
Nephrology Center DBA Paragon Health, Miami
Genesis Clinical Research, Tampa
Nephrology Associates PC, Birmingham
Southwest Renal Research Institute, Chattanooga
McComb Limited Care Facility, McComb
University Of Cincinnati, Cincinnati
Fresenius Medical Care Shorewood, Shorewood
Fresenius Medical Care of Evergreen Park, Evergreen Park
University South Alabama Medical Center, Mobile
Kidney Associates of Kansas City PC, Kansas City
U.S. Renal Care Inc., Mansfield
U.S. Renal Care Inc, Pine Bluff
U.S. Renal Care Inc, Fort Worth
U.S Renal Care Inc., Fort Worth
Nephrology-Hypertension Associates of Central New Jersey PA, North Brunswick
Pacific Renal Research Institute, Meridian
Arizona Kidney Disease and Hypertension Center, Phoenix
Renal Medicine Associates, Albuquerque
Academic Medical Research Institute, Los Angeles
Mark Lee MD, Inc, Whittier
North America Research Institute, Azusa
Pegasus Dialysis, LLC, Bakersfield
Central Nephrology Medical Group, Bakersfield
International Healthcare Systems S.A IHS Craiova Dialysis Center, Craiova
Nephrology and Hypertension Associates PC, Middlebury
DaVita Inc Clinical Research Unit, Stamford
Western New England Renal and Transplant Association, Springfield
Norbert Barlicki University Hospital No1. of the Medical University of Lodz, Lodz
International Healthcare Systems S.A IHS Fundeni Dialysis Center, Bucharest
S.C Gral Medical S.R.L, Bucharest
S.C Diaverum Romania S.R.I, Industriilor Diaverum Dialysis Center, Bucharest
SC Diaverum Romania SRL, Splai Dialysis Center, Bucharest
Lead Sponsor
Trevi Therapeutics
INDUSTRY